Growing community of inventors

Mountain View, CA, United States of America

Nathalie Scholler

Average Co-Inventor Count = 3.35

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 129

Nathalie SchollerDaniel J Powell (9 patents)Nathalie SchollerAizhi Zhao (7 patents)Nathalie SchollerKatarzyna Urbanska (4 patents)Nathalie SchollerDenarda Dangaj (4 patents)Nathalie SchollerDonald L Siegel (3 patents)Nathalie SchollerGeorge Coukos (3 patents)Nathalie SchollerNathalie Scholler (12 patents)Daniel J PowellDaniel J Powell (35 patents)Aizhi ZhaoAizhi Zhao (8 patents)Katarzyna UrbanskaKatarzyna Urbanska (5 patents)Denarda DangajDenarda Dangaj (4 patents)Donald L SiegelDonald L Siegel (26 patents)George CoukosGeorge Coukos (11 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Pennsylvania (12 from 2,620 patents)


12 patents:

1. 11912753 - Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens

2. 11078285 - Anti-TEM1 antibodies and uses thereof

3. 11041012 - Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens

4. 10961288 - Isolated B7-H4 specific compositions and methods of use thereof

5. 10266580 - Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens

6. 10259849 - Isolated B7-H4 specific compositions and methods of use thereof

7. 10160809 - Anti-TEM1 antibodies and uses thereof

8. 9708384 - Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens

9. 9556272 - Anti-TEM1 antibodies and uses thereof

10. 9422351 - Isolated B7-H4 specific compositions and methods of use thereof

11. 9279008 - Isolated B7-H4 specific compositions and methods of use thereof

12. 9272002 - Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…